152 related articles for article (PubMed ID: 16467413)
1. Common genetic variation in the prothrombin gene, hormone therapy, and incident nonfatal myocardial infarction in postmenopausal women.
Hindorff LA; Psaty BM; Carlson CS; Heckbert SR; Lumley T; Smith NL; Lemaitre RN; Rieder MJ; Nickerson DA; Reiner AP
Am J Epidemiol; 2006 Apr; 163(7):600-7. PubMed ID: 16467413
[TBL] [Abstract][Full Text] [Related]
2. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
[TBL] [Abstract][Full Text] [Related]
3. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
[TBL] [Abstract][Full Text] [Related]
4. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.
Heckbert SR; Weiss NS; Koepsell TD; Lemaitre RN; Smith NL; Siscovick DS; Lin D; Psaty BM
Arch Intern Med; 1997 Jun; 157(12):1330-6. PubMed ID: 9201007
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
[TBL] [Abstract][Full Text] [Related]
6. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
Baessler A; Fischer M; Mayer B; Koehler M; Wiedmann S; Stark K; Doering A; Erdmann J; Riegger G; Schunkert H; Kwitek AE; Hengstenberg C
Hum Mol Genet; 2007 Apr; 16(8):887-99. PubMed ID: 17324965
[TBL] [Abstract][Full Text] [Related]
7. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients.
Marciante KD; Bis JC; Rieder MJ; Reiner AP; Lumley T; Monks SA; Kooperberg C; Carlson C; Heckbert SR; Psaty BM
Am J Epidemiol; 2007 Jul; 166(1):19-27. PubMed ID: 17522061
[TBL] [Abstract][Full Text] [Related]
9. Association between PPARalpha gene polymorphisms and myocardial infarction.
Reinhard W; Stark K; Sedlacek K; Fischer M; Baessler A; Neureuther K; Weber S; Kaess B; Wiedmann S; Mitsching S; Lieb W; Erdmann J; Meisinger C; Doering A; Tolle R; Jeron A; Riegger G; Hengstenberg C
Clin Sci (Lond); 2008 Nov; 115(10):301-8. PubMed ID: 18336366
[TBL] [Abstract][Full Text] [Related]
10. Leisure-time physical activity and the risk of nonfatal myocardial infarction in postmenopausal women.
Lemaitre RN; Heckbert SR; Psaty BM; Siscovick DS
Arch Intern Med; 1995 Nov; 155(21):2302-8. PubMed ID: 7487254
[TBL] [Abstract][Full Text] [Related]
11. A common variant on chromosome 9p21 affects the risk of myocardial infarction.
Helgadottir A; Thorleifsson G; Manolescu A; Gretarsdottir S; Blondal T; Jonasdottir A; Jonasdottir A; Sigurdsson A; Baker A; Palsson A; Masson G; Gudbjartsson DF; Magnusson KP; Andersen K; Levey AI; Backman VM; Matthiasdottir S; Jonsdottir T; Palsson S; Einarsdottir H; Gunnarsdottir S; Gylfason A; Vaccarino V; Hooper WC; Reilly MP; Granger CB; Austin H; Rader DJ; Shah SH; Quyyumi AA; Gulcher JR; Thorgeirsson G; Thorsteinsdottir U; Kong A; Stefansson K
Science; 2007 Jun; 316(5830):1491-3. PubMed ID: 17478679
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I
Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
[TBL] [Abstract][Full Text] [Related]
13. No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease.
Eikelboom JW; Baker RI; Parsons R; Taylor RR; van Bockxmeer FM
Thromb Haemost; 1998 Dec; 80(6):878-80. PubMed ID: 9869153
[TBL] [Abstract][Full Text] [Related]
14. The myeloperoxidase gene and its influence on myocardial infarction in a Swedish population: protective role of the -129A allele in women.
Zotova E; Lyrenäs L; de Faire U; Morgenstern R; Gigante B; Bennet AM
Coron Artery Dis; 2009 Aug; 20(5):322-6. PubMed ID: 19543083
[TBL] [Abstract][Full Text] [Related]
15. Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women.
Song Y; You NC; Hsu YH; Sul J; Wang L; Tinker L; Eaton CB; Liu S
Hum Mol Genet; 2007 Dec; 16(23):2960-71. PubMed ID: 17855447
[TBL] [Abstract][Full Text] [Related]
16. Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.
Gigante B; Vikström M; Meuzelaar LS; Chernogubova E; Silveira A; Hooft FV; Hamsten A; de Faire U
Thromb Haemost; 2009 May; 101(5):943-53. PubMed ID: 19404549
[TBL] [Abstract][Full Text] [Related]
17. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal ischemic stroke in postmenopausal women.
Lemaitre RN; Psaty BM; Heckbert SR; Smith NL; Longstreth WT; Rosendaal FR
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):1051-2. PubMed ID: 12067921
[No Abstract] [Full Text] [Related]
19. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
McDermott DH; Yang Q; Kathiresan S; Cupples LA; Massaro JM; Keaney JF; Larson MG; Vasan RS; Hirschhorn JN; O'Donnell CJ; Murphy PM; Benjamin EJ
Circulation; 2005 Aug; 112(8):1113-20. PubMed ID: 16116069
[TBL] [Abstract][Full Text] [Related]
20. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study.
Kardys I; Klaver CC; Despriet DD; Bergen AA; Uitterlinden AG; Hofman A; Oostra BA; Van Duijn CM; de Jong PT; Witteman JC
J Am Coll Cardiol; 2006 Apr; 47(8):1568-75. PubMed ID: 16630992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
